C. Edlund et al., COMPARATIVE IN-VITRO ACTIVITY OF BAY-12-8039 AND 5 OTHER ANTIMICROBIAL AGENTS AGAINST ANAEROBIC-BACTERIA, European journal of clinical microbiology & infectious diseases, 17(3), 1998, pp. 193-195
The in vitro activity of BAY 12-8039 against 360 anaerobic clinical is
olates was determined by the agar dilution method and compared to that
of five other antimicrobial agents. BAY 12-8039 and imipenem were the
most active agents tested. The following MIC90 values were determined
for BAY 12-8039: Peptostreptococcus spp, (50 isolates), 1 mg/l; Propi
onibacterium acnes (30 isolates), 0.25 mg/l; Clostridium pel fringens
(30 isolates), 0.5 mg/l; Clostridium difficile (50 isolates), 2 mg/l;
Bacteroides fragilis (50 isolates), 1 mg/l; non-fragilis Bacteroides,
Porphyromonas, and Prevotella spp. (100 isolates), 2 mg/l; and Fusobac
terium spp. (50 isolates), 0.25 mg/l. The results of the present study
show that BAY 12-8039 may be useful in the treatment and prophylaxis
of anaerobic infections.